Drug: NAPROSYN Injury: Nephrolithiasis Quarter: 2016Q3
Total Records: 9 Number of Pages: 1
Event ID | DRUGNAME | PT | Drug Manufacturer | Patient Age | Sex | Weight | Date (YYYYMMDD) | Country |
---|---|---|---|---|---|---|---|---|
115950735 | NAPROSYN | Nephrolithiasis | AMGEN | 33.00 YR | F | 0 | 20160715 | CA |
117015188 | NAPROSYN | Nephrolithiasis | PFIZER | 33.00 YR | F | 0 | 20160729 | CA |
122683973 | NAPROSYN | Nephrolithiasis | JANSSEN | 76.00 YR | M | 79 KG | 20160808 | US |
126108401 | NAPROSYN | Nephrolithiasis | AMGEN | 0.00 | F | 0 | 20160801 | CA |
126163942 | NAPROSYN | Nephrolithiasis | PFIZER | 0.00 | F | 0 | 20160808 | CA |
126450271 | NAPROSYN | Nephrolithiasis | INTERCHEM | 37.00 YR | F | 0 | 20160811 | CA |
126590571 | NAPROSYN | Nephrolithiasis | INTERCHEM | 0.00 | F | 0 | 20160817 | CA |
968487813 | NAPROSYN | Nephrolithiasis | ROCHE | 48.54 YR | F | 116 KG | 20160822 | CA |
1026087135 | NAPROSYN | Nephrolithiasis | ROCHE | 57.17 YR | F | 64 KG | 20160914 | CA |
Total Records: 9 Number of Pages: 1